Bearish
CytoSorbents Corp stock (US23283M1018): Q1 miss keeps focus on growth and cash runway
CytoSorbents Corp reported weaker than expected Q1 2026 revenue of $8.9 million and a larger loss per share of -$0.05, missing analyst estimates. This...